<DOC>
	<DOCNO>NCT01011660</DOCNO>
	<brief_summary>The aim study investigate optimize treatment strategy hypertension , make patient reach blood pressure goal reduce cardio-cerebrovascular event . Objective Methods : Patients eligible inclusion study essential hypertension , 50-79 year age least one cardiovascular risk factor sign inform consent form . This project multi-centre , prospective randomize , ï¼Œopenlabel blind-endpoint evaluation control ( PROBE ) trial . 12000 patient randomly assign either low-dose Amlodipine+Telmisartan group Amlodipine+ diuretic group . Among patient serum cholesterol 4.0-6.1mmol/L , also randomize small dose statin-based regimen standard management regimen ; Patients also randomly assign intensive lifestyle intervention group standard intervention group accord community area patient .</brief_summary>
	<brief_title>Effects Angiotensin II Receptor Blocker Compared With Diuretics High-risk Hypertensive Patients</brief_title>
	<detailed_description>This study aim observe main outcome ( stroke , myocardial infarction death cardiovascular disease ) differences different group .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<mesh_term>Amiloride</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>essential hypertension 5079 year old least one cardiovascular risk factor sign consent form secondary hypertension attack cerebrovascular event myocardial infarction within recent 3 month coexistence severe cardiomyopathy , rheumatic congenital heart diseases unstable angina severe hepatopathy nephropathy ( ALT elevation &gt; 2 fold serum creatinine &gt; 2.5mg/dl ) malignant tumor gout woman take contraceptive pregnancy allergic history research drug validate contradiction research drug participate clinical trial unable longterm followup poor compliance unsuitable clinical trial discretion doctor charge</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>hypertension</keyword>
	<keyword>cardiovascular risk factor</keyword>
	<keyword>drug intervention</keyword>
	<keyword>lipid-lowering therapy</keyword>
	<keyword>50-79 year age</keyword>
	<keyword>sign</keyword>
	<keyword>inform</keyword>
	<keyword>consent</keyword>
	<keyword>form</keyword>
</DOC>